NEUROCRINE BIOSCIENCES INC — Director's Dealing 2015

Jan 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEUROCRINE BIOSCIENCES INC (NBIX)
CIK: 0000914475
Period of Report: 2015-01-12

Reporting Person: OBrien Christopher Flint (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-12	Common Stock	S	1750	$28.41	Disposed	98294	Direct

Footnotes

F1: Sale of 1,750 shares of common stock issued upon vesting of 3,500 restricted stock units on January 12, 2015 to cover payroll and withholding taxes, with the balance of the shares (1,750) maintained by the Reporting Person; the sale was affected by a broker pursuant to instructions set forth in a Rule 10b5-1 plan adopted by the Reporting Person and delivered to the broker on May 28, 2013.

F2: Represents a weighted average sales price per share. The prices actually received ranged from $27.27 to $29.57. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.